Novo Nordisk's pre-market decline narrowed to 20%, with a previous drop of nearly 30% being the largest single day decline on record
六月清晨搅
发表于 2024-12-20 20:34:55
136
0
0
According to AI News, on December 20th, the pre-market decline of Novo Nordisk's US stock market narrowed to 20%, after a previous drop of nearly 30%, the largest single day decline on record, as the trial results of Novo Nordisk's weight loss drug CagriSema did not meet expectations.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Top 20 US Stock Exchange Transactions: TSMC Increases Over 9%, Market Value Exceeds $1 Trillion
- US stocks close down: Nasdaq falls more than 2%, large tech stocks generally decline
- After the US election, Tesla's stock price surged by nearly 15%. Elon Musk's net worth increased by $20.9 billion in a single day
- Tesla: Nevada Gigafactory produces over 1000 units of household energy storage system Powerwall in a single day
- Supermicro Computer's US stock rose 40% after closing, as it submitted a compliance plan to NASDAQ
- Pinduoduo's pre-market decline widens to 13%
- Top 20 US Stock Transactions: Adobe's Poor Performance, Stock Price Falls 13.7%
- Novo Nordisk's pre-market decline narrows to 20%
- Top 20 US Stock Transactions: Tesla Falls Nearly 5%, Domestic Car Companies Launch Price Reduction Promotion Strategy
- Faraday Future skyrockets by 78% after announcing $30 million in financing
